About the HealthTech and Medicines Knowledge Transfer Network (KTN)
The HealthTech and Medicines Knowledge Transfer Network (KTN) is dedicated to accelerating innovation and technology exploitation in the broad health industries sector funded by theTechnology Strategy Board, the UK’s national innovation agency. The KTN provides its extensive membership base with support for business innovation through partnerships, funding and knowledge transfer:
- Connecting partners: Bringing together and facilitating collaborations with a common goal
- Access to funding: Identify and influence new and existing sources of funding
- Knowledge transfer: Opening doors to wider networks of people, organisations
The KTN supports its members by facilitating knowledge of technologies and relationships with experts, while also providing a breadth of contacts, knowledge of the UK innovation landscape and advice on funding opportunities.
Benefits of membership of the KTN can provide access to:
- Potential practitioner network into industry and industry friendly academia
- Technology Strategy Board, National and EU funding competitions
- Impartial advice and access to the full KTN team
- Key individuals within the community – putting you in touch with the right partners for forming collaborations
- Networking opportunities and events
- Technical Groups across a number of industry-led topics
By joining the KTN, members gain access to a dynamic, UK-wide knowledge transfer network covering all aspects of medical devices, diagnostics and medicines, with a focus on the priority areas of:
- Biopharmaceutical and Bioprocessing
- Medical Devices and Diagnostics
- Regenerative Medicines
- Assisted Living
- Detection and Identification of Infectious Agents
- Stratified Medicines
For more information and details on how to engage with the HealthTech and Medicines KTN community, visit www.innovateuk.org/healthktn
bioProcessUK is a partner of the HealthTech and Medicines KTN and delivers the KTN biopharmaceutical and bioprocessing agenda. This priority area focuses on the underpinning technology that is essential to make biopharmaceutical products. Biopharmaceuticals (biological medicines) is the fastest growing sector in the pharmaceutical industry, accounting for more than 10% of the total drug sales and 30% of the products in the pipeline today. The UK has the second highest number of biopharmaceuticals in development worldwide.
The Annual bioProcessUK Conference has become the UK’s leading technical networking meeting for professionals developing biological medicines.
To find out more about the biopharmaceuticals and bioprocessing priority area please visit: https://ktn.innovateuk.org/web/bioprocessing